Abstract:The activation of pregnane X receptor (PXR), a member of the nuclear receptor (NR) superfamily, can mediate potential drugdrug interactions, and therefore, prediction of PXR activation is of great importance for evaluating drug metabolism and toxicity. In this study, based on 532 structurally diverse compounds, we present a comprehensive analysis with the aim to build accurate classification models for distinguishing PXR activators from nonactivators by using a naive Bayesian classification technique. First, the distributions of eight important molecular physicochemical properties of PXR activators versus nonactivators were compared, illustrating that the hydrophobicity-related molecular descriptors (AlogP and log D) show slightly better capability to discriminate PXR activators from nonactivators than the others. Then, based on molecular physicochemical properties, VolSurf descriptors, and molecular fingerprints, naive Bayesian classifiers were developed to separate PXR activators from nonactivators. The results demonstrate that the introduction of molecular fingerprints is quite essential to enhance the prediction accuracy of the classifiers. The best Bayesian classifier based on the 21 physicochemical properties, VolSurf descriptors, and LCFC_10 fingerprints descriptors yields a prediction accuracy of 92.7% for the training set based on leave-one-out (LOO) cross-validation and of 85.2% for the test set. Moreover, by exploring the important structural fragments derived from the best Bayesian classifier, we observed that flexibility is an important structural pattern for PXR activation. In addition, chemical compounds containing more halogen atoms, unsaturated alkanes chains relevant to pi-pi stacking, and fewer nitrogen atoms tend to be PXR activators. We believe that the naive Bayesian classifier can be used as a reliable virtual screening tool to predict PXR activation in the drug design and discovery pipeline.

Advances in Search for Pregnane X Receptor

Regulation of Pregnane X Receptor(PXR)by Herbal Medicines

Function of pregnane X receptor in drug mechanism and research progress

Progresses of researches on the correlation between pregnane X receptor and CYP3A

The role of pregnane X receptor (PXR) in substance metabolism

Advances in regulation of pregnane X receptor-mediated drug transporter

Role of pregnane X receptor in chemotherapeutic treatment

Regulation of PXR in drug metabolism: chemical and structural perspectives

Dietary phytochemicals as modulators of human pregnane X receptor

Advances in the Research of Pregnane X Receptor and Constitutive Androstane Receptor

Absorption, Distribution, Metabolism, Excretion, and Toxicity Evaluation in Drug Discovery. 14. Prediction of Human Pregnane X Receptor Activators by Using Naive Bayesian Classification Technique.

Pregnane X Receptor As the “sensor and Effector” in Regulating Epigenome

Functions of Pregnane X Receptor in Self-Detoxification

Biology of Pxr: Role in Drug-Hormone Interactions

Pregnane X receptor as the "sensor and effector" in regulating epigenome.

Regulation of drug resistance by human pregnane X receptor in breast cancer.

The transcriptional regulation of drug enzymes and transporters mediated by Pregnane X receptor and its significant role in multidrug resistance

Regulation of human pregnane X receptor and its target gene cytochrome P450 3A4 by Chinese herbal compounds and a molecular docking study.

A Novel Pregnane X Receptor-Mediated and Sterol Regulatory Element-Binding Protein-Independent Lipogenic Pathway

Identification and Validation of Novel Human Pregnane X Receptor Activators among Prescribed Drugs Via Ligand-Based Virtual Screening

Evaluation of pregnane X receptor (PXR)-mediated CYP3A4 drug-drug interactions in drug development